Please assess the completion status of the following clinical trial:

Trial Title: The LIFE Study - Lifestyle Interventions and Independence for Elders

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. age 70 to 89 years; (2) summary score \<10 on the short physical performance battery (SPPB) (45% are \<8);90 (3) sedentary lifestyle; (4) ability to complete the 400 m walk test without an assistive device; and (5) willingness to be randomized to either intervention group.~   Exclusion Criteria:~   Exclusion Criteria for Factors that May Limit Adherence to Interventions or Affect Conduct of the Trial • Unable or unwilling to give informed consent or accept randomization in either study group • Current diagnosis of schizophrenia, other psychotic disorders, or bipolar disorder~  * Current consumption of more than 14 alcoholic drinks per week~  * Plans to relocate to out of the study area within the next 2 years or plans to be out of the study area for more than 6 consecutive weeks in the next year~  * Self-reported inability to walk across a small room~  * The use of a walker to complete the 400 m walk and/or unable to complete the 400 m walk without sitting down or the help of another person~  * Another member of the household is a participant in the Life Study~  * Residence too far from the intervention site~  * Residence in a nursing home~  * Difficulty in communication with study personnel due to speech or hearing problems~  * Modified Mini-Mental State Exam (3MSE) score below the cutoff for education:~   African American, 9+ yrs 76, \<9 yrs 70; English Speaking Non-African American, 9+ yrs 80, \<9 yrs 76; Spanish Speaking, 9+ yrs 80, \<9 yrs 70~  * Participation in LIFE-Pilot study~  * Other medical, psychiatric, or behavioral factors that in the judgment of the Principal Investigator may interfere with study participation or the ability to follow the intervention protocol~   Exclusion Criteria for Underlying Diseases Likely to Limit Lifespan and/or Affect the Safety of the Interventions~   • Severe arthritis (either osteoarthritis or rheumatoid arthritis)~   • Cancer requiring treatment in the past three years, except for non-melanoma skin cancers or cancers that have clearly been cured or in the opinion of the investigator carry an excellent prognosis (e.g., Stage 1 cervical cancer)~   • Lung disease requiring either regular use of corticosteroid pills or injections or the use of supplemental oxygen~   • Development of chest pain or severe shortness of breath on a 400 m self-paced walk test~   • Cardiovascular disease (including New York Heart Association Class III or IV congestive heart failure, clinically significant aortic stenosis, history or cardiac arrest, use of a cardiac defibrillator or uncontrolled angina)~   • Parkinson's disease or other serious neurological disorder~   • Renal disease requiring dialysis~   • Other illness of such severity that life expectancy is considered to be less than 12 months~   • Conditions not specifically mentioned above may serve as criteria for exclusion at the discretion of the clinical site~   Temporary Exclusion Criteria~   • Uncontrolled hypertension (systolic blood pressure \> 200 mmHg and/or diastolic blood pressure \> 110 mmHg).~   • Uncontrolled diabetes with recent weight loss, diabetic coma or frequent insulin reactions.~  * Stroke, hip fracture, hip or knee replacement, or spinal surgery in the past 6 months.~  * Serious conduction disorder (e.g., 3rd degree heart block), uncontrolled arrhythmia, or new Q waves or ST-segment depressions (\>3 mm) on ECG.~  * Myocardial infarction, major heart surgery (i.e., valve replacement or bypass surgery), stroke, deep vein thrombosis or pulmonary embolus in the past 6 months.~  * Undergoing physical therapy or cardiopulmonary rehabilitation~  * Currently enrolled in another randomized trial involving lifestyle or pharmaceutical interventions

- Gender: ALL
- Minimum Age: 70 Years
- Maximum Age: 89 Years
- Healthy Volunteers: f

Study Arms:
- Physical Activity (Type: ACTIVE_COMPARATOR): The physical activity intervention consists primarily of walking at moderate intensity, lower extremity resistance exercises, balance exercises, stretching and behavioral counseling.
- Successful Aging (Type: ACTIVE_COMPARATOR): The successful aging intervention consists of health education seminars regarding health-related matters and upper extremity stretching exercises.

Based on this trial design, predict the completion outcome and termination type (if applicable).